Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma Academic Article Article uri icon

Overview

MeSH Major

  • Dependovirus
  • Factor VIII
  • Genetic Therapy
  • Genetic Variation
  • Genetic Vectors
  • Hemophilia A

abstract

  • Overall, the activity of edatrexate in this study, dominated by patients with either visceral or vascular sarcoma, was poor. However, the responses observed in patients with metastatic MFH suggests that further evaluation of edatrexate in patients with soft tissue sarcoma is warranted.

publication date

  • January 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19930801)72:3<766::AID-CNCR2820720321>3.0.CO;2-Z

PubMed ID

  • 8392904

Additional Document Info

start page

  • 766

end page

  • 70

volume

  • 72

number

  • 3